New positron emission tomography tracer [11 C]carvedilol reveals P-glycoprotein modulation kinetics-Reference-Cited by-同舟云学术

New positron emission tomography tracer [11 C]carvedilol reveals P-glycoprotein modulation kinetics

Published:2005-08 Issue:8 Volume:145 Page:1045-1051
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Bart Joost,Dijkers Eli C F,Wegman Theodora D,de Vries Elisabeth G E,van der Graaf Winette T A,Groen Harry J M,Vaalburg Willem,Willemsen Antoon T M,Hendrikse N Harry

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0706283/fullpdf

Reference25 articles.

1. Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar);ADVANI;Blood,1999

2. Increased (99m)Tc-Sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576;AGRAWAL;Clin. Cancer Res.,2003

3. Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET;BART;Neuroimage,2003

4. Circumvention of chemotherapy-induced myelosuppression by transfer of the mdr1 gene;BOESEN;Biotherapy,1993

5. Octanol-water partition: searching for predictive models;BUCHWALD;Curr. Med. Chem.,1998

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the effect of concurrently administered carvedilol, atorvastatin and bile salts on intestinal absorption of linagliptin;Journal of Pharmacy and Pharmacology;2023-02-28

2. Blood–brain barrier permeable β-blockers linked to lower risk of Alzheimer’s disease in hypertension;Brain;2022-02-23

3. Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development;Pharmaceutics;2020-03-24

4. Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease;The Journal of Clinical Pharmacology;2019-07-28

5. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats;Journal of Pharmacy and Pharmacology;2019-01-21